Tag: News

Consulting

BIO International: Discover the Latest in Innovative Rare Disease Trial Design

DURHAM, N.C., June 5, 2019 — Premier Research is sponsoring the Orphan & Rare Disease session track at this year’s BIO International Convention, June 3-6 in Philadelphia. Our own Angi Robinson, vice president for clinical development services in rare diseases and pediatrics, will participate in the panel discussion Rare Finds: Innovative Clinical Trial Design for...

Medical Device and Dermatology Experts Presenting at MAGI East Conference

DURHAM, N.C., May 3, 2019 — Two of our top experts, Joanne Emmett, Vice President of Clinical Development Services for Medical Device and Diagnostics, and Jasmina Jankicevic, MD, MSc, CCRP, Dermatologist, Executive Director, Medical Affairs, will participate in three sessions at the MAGI 2019 East Clinical Research Conference in Boston. Emmett, head of medical devices,...

Top Physician to Lead Cell-Based Therapy Panel at Clin Ops West

DURHAM, N.C., April 25, 2019 — Premier Research will moderate a panel on cell-based therapies on Tuesday, April 30, at the Clinical Operations in Oncology Trials West Coast meeting in Burlingame, Calif. Colin Hayward, the company’s chief medical officer, will lead a discussion about how researchers are overcoming the challenges inherent in creating cell-based cancer...

Patient and Stakeholder Engagement

Patient Engagement Expert to Address Orphan Drug Congress April 11

DURHAM, N.C., March 25, 2019 — Premier Research’s head of patient engagement will discuss a patient-centered look at drug development at the World Orphan Drug Congress (WODC) USA in Oxon Hill, Maryland. Juliet Moritz, Premier Research’s newly appointed vice president of patient and stakeholder engagement (PASE), will present From the End to the Beginning: A Patient-Centric...

Patient and Stakeholder Engagement

Premier Research Champions Patient Advocacy Community

DURHAM, N.C., February 28, 2019 — As part of its commitment to supporting the patient advocacy community and as a kickoff to Rare Disease Day on February 28 and March as Rare Disease Month at the company, Premier Research is announcing both a new scholarship for rare disease patient advocates in partnership with Professional Patient...

Premier Research Names Dr. Mike Wilkinson Chief Operating Officer

DURHAM, N.C., February 5, 2019 — Premier Research has named contract research organization (CRO) industry and military veteran Dr. Mike Wilkinson as its new Chief Operating Officer. Dr. Wilkinson brings a diverse background of industry and public service to his role of overseeing the company’s day-to-day operations and advancing its mission to support the world’s...

Medical and Regulatory Affairs

Chief Medical Officer Discussing Early Regulatory Engagement at OCT Southern California

DURHAM, N.C., November 2, 2018 — Premier Research’s Chief Medical Officer will discuss bridging the regulatory engagement gap from pre-clinical to first patient in at Outsourcing in Clinical Trials New England, November 6, in Boston. Dr. Colin Hayward will address strategic and practical considerations for engaging with regulatory bodies on the opening day of the annual...

Rare Disease and Pediatrics Expert to Address WODC Europe November 7

DURHAM, N.C., October 30, 2018 — Angi Robinson, Executive Director for Rare Disease and Pediatrics at Premier Research, will discuss clinical development strategies for genetic rare disease research November 7 at the World Orphan Drug Congress in Barcelona. Ms. Robinson’s presentation, starting at 2:20 p.m., will examine management of confirmatory testing and specialty labs, the...

Premier Research Asia-Pacific Expansion Helps Biotech Advance Life-Changing Therapies

DURHAM, N.C., September 27, 2018 — Premier Research, a leading provider of clinical development and consulting services to biotech and specialty pharma companies, has again expanded its presence in the Asia-Pacific region to include South Korea, Singapore, and Taiwan. The moves increase activities in Australia and New Zealand, where Premier has been conducting clinical trials...

Medical and Regulatory Affairs

Evaluating Europe’s New Device Rules: Join Us in La Jolla September 26

DURHAM, N.C., September 20, 2018 — Implementation of Europe’s new medical device regulations in 2017 started a transition that gives device companies up to five years to fully comply with strict new quality standards. But exactly what is changing, and why? And how will the new MDR and IVDR rules affect the players in this...